Tower Research Capital (TRC)’s Intensity Therapeutics INTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14K | Buy |
13,491
+11,115
| +468% | +$3.41K | ﹤0.01% | 4373 |
|
|
2025
Q1 | $4.68K | Sell |
2,376
-272
| -10% | -$536 | ﹤0.01% | 4217 |
|
|
2024
Q4 | $4.66K | Buy |
2,648
+1,479
| +127% | +$2.6K | ﹤0.01% | 4423 |
|
|
2024
Q3 | $4.43K | Sell |
1,169
-1,182
| -50% | -$4.48K | ﹤0.01% | 4546 |
|
|
2024
Q2 | $11.6K | Sell |
2,351
-4,682
| -67% | -$23.1K | ﹤0.01% | 4073 |
|
|
2024
Q1 | $37.5K | Buy |
+7,033
| New | +$37.5K | ﹤0.01% | 2472 |
|
|
2023
Q4 | – | Sell |
-1,027
| Closed | -$4.29K | – | 6046 |
|
|
2023
Q3 | $4.29K | Buy |
+1,027
| New | +$4.29K | ﹤0.01% | 4890 |
|